gilberto lopes

Top lung cancer developments in 2025? My take: 2025 wasn’t about a single disruptive moment. It was about consolidation, maturation, and a few long-awaited signals finally turning solid. 1) MARIPOSA delivers OS Amivantamab + lazertinib demonstrates an overall survival benefit

Incredibly proud of @Kyle__Edwards - one of my first and the best student / mentee so far - watched him grow from MS2 @UMiamiHealth to now a resident at @HopkinsMedicine . From oral presentations as a student to leading multiple projects at a level of a high-functioning resident

Honored to share I matched @HopkinsMedicine! Today is also my Mom’s birthday. She passed in 2023 after a 6-year battle with DLBCL. Her fight drives my passion for patient care, cancer research, and health equity. I’m excited to train at Hopkins to continue this work! #Match2026

RT @OscarTahuahua: One of the most effective adjuvant therapies in oncology Exercise 🏋️⛹️🏃 Costs ~$3–4K over 3 years vs >$100K/year for ma…

During the 14th Annual Women’s Health Conference in the Cayman Islands, Dr. John P. Diaz, Dr. Yonatan Weiss, and Dr. Yvonne Koch led the panel discussion sharing how multidisciplinary collaboration helps deliver better outcomes for women facing cancer. #BaptistHealthInternational

RT @MedwatchKate: What happened this week in #LungCancer: 1️⃣ Resistance-Informed Sequencing in EGFR mNSCLC In 1L EGFR-mutant NSCLC, trea…

RT @StephenVLiu: On the next episode of the @IASLC podcast, Lung Cancer Considered, I sit down with members of the Global Policy and Partne…

#UMiami’s inaugural Research Mentoring Summit aims to advance mentoring and elevate the University’s research efforts. bit.ly/4bT7qQH